[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100420182":3},{"organization":4,"armGroups":7,"interventions":26,"overallOfficials":78,"centralContacts":82,"locations":87,"responsibleParty":106,"collaborators":77,"id":108,"slug":109,"hasResults":110,"nctId":111,"briefTitle":112,"officialTitle":113,"acronym":77,"eligibilityCriteria":114,"healthyVolunteers":110,"sex":115,"minAge":116,"maxAge":77,"enrollmentInfo":117,"targetDuration":77,"studyType":120,"phases":121,"briefSummary":123,"conditions":124,"keywords":77,"overallStatus":90,"whyStopped":77,"lastUpdateSubmitDate":129,"lastUpdatePostDateStruct":130,"startDateStruct":133,"completionDateStruct":135,"leadSponsor":137,"locationsCount":138},{"fullName":5,"class":6},"M.D. Anderson Cancer Center","OTHER",[8,17,22],{"label":9,"type":10,"description":11,"interventionNames":12},"Group 1, Arm I (intense follow up)","EXPERIMENTAL","Patients undergo intense follow-up every 3 months for 2 years consisting of restaging with CT-chest and imaging of the primary site.",[13,14,15,16],"Procedure: Computed Tomography","Procedure: Follow-Up","Procedure: Imaging Technique","Other: Questionnaire Administration",{"label":18,"type":10,"description":19,"interventionNames":20},"Group 1, Arm II (limited follow-up)","Patients undergo limited follow-up every 6 months for 2 years consisting of restaging with either CT-chest or CXR and imaging of the primary site.",[21,13,14,15,16],"Procedure: Chest Radiography",{"label":23,"type":10,"description":24,"interventionNames":25},"Group 2 (intense follow up)","Patients undergo intense follow-up every 3 months for 2 years as in Group 1, Arm I.",[13,14,15,16],[27,34,46,58,62,73],{"type":28,"name":29,"description":30,"armGroupLabels":31,"otherNames":32},"PROCEDURE","Chest Radiography","Undergo CXR",[18],[33],"Chest X-ray",{"type":28,"name":35,"description":36,"armGroupLabels":37,"otherNames":38},"Computed Tomography","Undergo CT-chest",[9,18,23],[39,40,41,42,43,44,45],"CAT","CAT Scan","Computerized Axial Tomography","Computerized Tomography","CT","CT Scan","tomography",{"type":28,"name":47,"description":48,"armGroupLabels":49,"otherNames":50},"Follow-Up","Undergo intense follow-up",[9,23],[51,52,53,54,55,56,57],"Active Follow-up","Clinical Signs Follow-up","CLSFUP","Follow Up","follow_up","Followed","Followup",{"type":28,"name":47,"description":59,"armGroupLabels":60,"otherNames":61},"Undergo limited follow-up",[18],[51,52,53,54,55,56,57],{"type":28,"name":63,"description":64,"armGroupLabels":65,"otherNames":66},"Imaging Technique","Undergo imaging",[9,18,23],[67,68,69,70,71,72],"Diagnostic Imaging Technique","Imaging","imaging procedure","Imaging Procedures","Imaging, Not Otherwise Specified","Medical Imaging",{"type":6,"name":74,"description":75,"armGroupLabels":76,"otherNames":77},"Questionnaire Administration","Ancillary studies",[9,18,23],null,[79],{"name":80,"affiliation":5,"role":81},"Christina L Roland, MD","PRINCIPAL_INVESTIGATOR",[83],{"name":80,"role":84,"phone":85,"phoneExt":77,"email":86},"CONTACT","713-792-6940","clroland@mdanderson.org",[88],{"facility":89,"status":90,"city":91,"state":92,"zip":93,"country":94,"countryCode":95,"cosmosGeoPoint":96,"geoPoint":101,"contacts":102},"M D Anderson Cancer Center","RECRUITING","Houston","Texas","77030","United States","US",{"type":97,"coordinates":98},"Point",[99,100],-95.36327,29.76328,{"lat":100,"lon":99},[103,105],{"name":104,"role":84,"phone":85,"phoneExt":77,"email":86},"Christina L. Roland",{"name":104,"role":81,"phone":77,"phoneExt":77,"email":77},{"type":107,"investigatorFullName":77,"investigatorTitle":77,"investigatorAffiliation":77,"oldNameTitle":77,"oldOrganization":77},"SPONSOR","100420182","phase-2-evaluating-the-impact-of-limited-compared-with-intense-post-operative-surveillance-on-patient-reported-outcomes-in-patients-with-stage-ii-iii-soft-tissue-sarcoma-of-the-trunk-and-extremities-100420182",false,"NCT04751409","Evaluating the Impact of Limited Compared With Intense Post-Operative Surveillance on Patient-Reported Outcomes in Patients With Stage II-III Soft Tissue Sarcoma of the Trunk and Extremities","Evaluating the Impact of Limited vs. Intense Post-Operative Surveillance on Patient-Reported Outcomes in Patients With Soft Tissue Sarcoma","IInclusion Criteria:\n\n* ≥18 years old\n* Completion of sarcoma therapy (chemotherapy, radiation therapy and\u002For surgery) within 8-14 weeks of study enrollment\n* Willingness to complete surveys x 2 years\n\nExclusion Criteria:\n\n* Documented metastatic disease at the time of enrollment\n* Non-English-speaking patients\n\nPregnant women will be included in this clinical trial.","ALL","18 Years",{"count":118,"type":119},227,"ESTIMATED","INTERVENTIONAL",[122],"PHASE2","This phase II trial studies how anxiety is affected by 2 types of follow-up after surgery, limited follow-up and intense follow-up, in patients with stage II-III soft tissue sarcoma of the trunk and extremities. In cancer survivors, the fear of cancer coming back (recurring) is common and may persist long after the end of treatment. It may also be exacerbated by return visits for imaging (surveillance). The purpose of this study is to determine how patients' anxiety and other cancer-related outcomes are affected by how often surveillance is done.",[125,126,127,128],"Stage II Soft Tissue Sarcoma of the Trunk and Extremities AJCC v8","Stage III Soft Tissue Sarcoma of the Trunk and Extremities AJCC v8","Stage IIIA Soft Tissue Sarcoma of the Trunk and Extremities AJCC v8","Stage IIIB Soft Tissue Sarcoma of the Trunk and Extremities AJCC v8","2026-03-03",{"date":131,"type":132},"2026-03-05","ACTUAL",{"date":134,"type":132},"2020-12-28",{"date":136,"type":119},"2027-12-31",{"name":5,"class":6},1]